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Purpose: To describe the distribution of corneal hysteresis (CH) in a large cohort and explore its associated
factors and possible clinical applications.
Design: Cross-sectional study within the UK Biobank, a large cohort study in the United Kingdom.
Participants: We analyzed CH data from 93 345 eligible participants in the UK Biobank cohort, aged 40 to 69
years.
Methods: All analyses were performed using left eye data. Linear regression models were used to evaluate
associations between CH and demographic, lifestyle, ocular, and systemic variables. Piecewise logistic regres-
sion models were used to explore the relationship between self-reported glaucoma and CH.
Main Outcome Measures: Corneal hysteresis (mmHg).
Results: The mean CH was 10.6 mmHg (10.4 mmHg in male and 10.8 mmHg in female participants). After
adjusting for covariables, CH was signiﬁcantly negatively associated with male sex, age, black ethnicity, self-
reported glaucoma, diastolic blood pressure, and height. Corneal hysteresis was signiﬁcantly positively associ-
ated with smoking, hyperopia, diabetes, systemic lupus erythematosus (SLE), greater deprivation (Townsend
index), and Goldmann-correlated intraocular pressure (IOPg). Self-reported glaucoma and CH were signiﬁcantly
associated when CH was less than 10.1 mmHg (odds ratio, 0.86; 95% conﬁdence interval, 0.79e0.94 per mmHg
CH increase) after adjusting for covariables. When CH exceeded 10.1 mmHg, there was no signiﬁcant association
between CH and self-reported glaucoma.
Conclusions: In our analyses, CH was signiﬁcantly associated with factors including age, sex, and ethnicity,
which should be taken into account when interpreting CH values. In our cohort, lower CH was signiﬁcantly
associated with a higher prevalence of self-reported glaucoma when CH was less than 10.1 mmHg. Corneal
hysteresis may serve as a biomarker aiding glaucoma case detection. Ophthalmology 2019;126:1500-
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Supplemental material available at www.aaojournal.org.It is well recognized that variation in central corneal thick-
ness (CCT) inﬂuences the accuracy of intraocular pressure
(IOP) measurements.1-3 It has also been hypothesized that
CCT independently inﬂuences the risk of glaucoma, with
thin CCT evidenced in those at highest risk.4 However, this
view is not universally accepted, because one particular
high-risk group (African Americans) typically has thinner
CCT than people of European heritage.5 A plausible
alternative explanation is that thin CCT is a biomarker for
race and identiﬁes those at highest risk, attributable to
other ocular or systemic factors.
Corneal hysteresis (CH) offers an alternative index of
corneal biomechanical characteristics to CCT and reﬂects
the viscoelastic damping effect of corneal tissues, deﬁned as
the difference in air pulse pressure between inward and
outward applanation forces.6,7 Recent evidence indicates1500 Crown Copyright ª 2019 Published by Elsevier Inc. on behalf of the Ame
Academy of OphthalmologyCH can provide valuable information related to the pres-
ence, progression, and response to therapy of glaucoma.8,9
Corneal hysteresis can be measured simultaneously with
IOP using noncontact tonometry with augmented function-
ality. Differences in CH have been reported not only in
glaucoma but also in many systemic diseases, including
thyroid eye disease,10 rheumatoid arthritis,11 psoriasis,12
acromegaly,13 and myotonic dystrophy,14 which suggests
CH may play a clinical role in ﬁelds other than
ophthalmology. Previous studies on CH are limited by
small sample sizes.15,16 The distribution of CH and its as-
sociations with demographic, ocular, and systemic variables
remain to be accurately determined and conﬁrmed in a large
sample.
The UK Biobank is one of the largest prospective pop-
ulation cohort studies in the world. In this study, we aimedrican https://doi.org/10.1016/j.ophtha.2019.06.029
ISSN 0161-6420/19
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and explore its associations, including the relationship be-
tween CH and self-reported glaucoma. We also tested the
association between CH and 16 self-reported diseases
selected on the basis of existing literature.10-13
Methods
Study Population
The UK Biobank is a multisite community-based cohort study with
502 544 participants. All UK residents aged 40 to 69 years who
registered with the National Health Service and lived within 25
miles of any of the 22 assessment centers were invited to join the
study. The initial visit assessments took place between 2006 and
2010. Eye assessments were carried out from 2009 in 6 recruitment
centers (5 in England and 1 in Wales) that enrolled 133 953 par-
ticipants. The UK Biobank study was approved by the North West
Multi-centre Research Ethics Committee (Reference No. 06/
MRE08/65) and adhered to the tenets of the Declaration of Hel-
sinki. Written consent was obtained from every participant. More
detailed information and protocols for UK Biobank are available
online (http://www.ukbiobank.ac.uk/).
Ethnicity was self-reported by participants and selected from
white, Asian, black, Chinese, mixed, and other ethnic backgrounds.
Socioeconomic status was derived using the Townsend deprivation
index estimated using residence postcodes. This represents an
indicative measure of economic deprivation in an area, and higher
scores indicate worse socioeconomic status.17
Measurements
Cohort characteristics and ophthalmic measures have been
described.18 Visual acuity was measured using a bespoke
computerized logarithm of the minimum angle of resolution
acuity measure conforming to British Standard BS4274-1968,19
with left eye following right eye. Autorefraction was performed
with the RC5000 Auto Refkeratometer (Tomey, Tokyo, Japan).
After measuring visual acuity and refraction, CH and Goldmann-
correlated IOP (IOPg) were measured with the Reichert Ocular
Response Analyzer (ORA, Reichert, Inc., Depew, NY) according
to a predetermined protocol (available at http://biobank.ctsu.
ox.ac.uk/crystal/refer.cgi?id¼100236). Participants who had any
eye surgery within the preceding 4 weeks were excluded from
tests. The measurements were performed ﬁrst in the right eye and
taken only once in each eye. If participants blinked during the test,
a further measurement was attempted.
Blood pressure was measured with an automatic blood pressure
monitor, HEM-70151T (Omron, Hoofddorp, The Netherlands).
Two measurements were performed for each participant, and the
average was used for analysis if the values of both were available.
Height was measured with the Seca 202 instrument (Seca, Bir-
mingham, UK).
Medical History
All diseases were self-reported by participants via verbal
interviews conducted by trained nurses or via touchscreen ques-
tionnaires. Self-reported eye disorder status was collected in the
verbal interview or selected by participants from a list of eye dis-
orders in response to the question “Has a doctor told you that you
have any of the following problems with your eyes?” The list of
eye disorders was as follows:Figure 1. Flowchart showing participants included for analysis. CH ¼
corneal hysteresis; D ¼ diopter; IOPg ¼ Goldmann-correlated intraocular
pressure.1. Diabetes-related eye disease.
2. Glaucoma.3. Injury or trauma resulting in loss of vision.
4. Cataract.
5. Macular degeneration.
6. Other serious eye condition.
7. None of the above.
8. Prefer not to answer.
9. Do not know.Smoking and alcohol consumption were self-reported via
touchscreen questionnaires. Smoking status was trichotomized for
the purpose of analysis to current smokers, ex-smokers, and those
who have never smoked. Alcohol consumption was pentacho-
tomized to daily/almost daily, weekly or more often, monthly or
more often, occasional, and never. The use of IOP-lowering
medications was recorded by trained interviewers. Only currently
and regularly used ones were recorded. Intraocular
pressureelowering medication status was dichotomized to user and
nonuser for analysis. More detailed information about all variables
is available online (http://biobank.ctsu.ox.ac.uk/crystal/index.cgi).
Eligibility Criteria
All participants who had available ORA data (CH and IOPg) in the
left eye were used for this analysis. Participants who met any
exclusion criteria in Figure 1 were excluded from the analyses;
0.5% of participants who were younger than 40 years or older
than 69 years of age were excluded on the basis of the UK
Biobank eligibility criteria. Extreme values (lowest 0.5% and
highest 0.5%) of CH and IOPg may represent measurement
errors and were excluded. We excluded participants with a1501
Table 1. Distribution of Corneal Hysteresis (mmHg) Stratiﬁed by Age, Gender, and Ethnicity in 92 137 Left Eyes without Self-Reported Glaucoma*
40e44 Yrs 45e49 Yrs 50e54 Yrs 55e59 Yrs 60e64 Yrs 65e69 Yrs Py Total
Female
White 11.31.9 (4127) 11.21.8 (5600) 11.01.8 (6877) 10.91.9 (8099) 10.71.8 (11 768) 10.51.8 (8449) 1.8210174 10.81.8 (44 920)
Asian 10.71.8 (315) 10.71.7 (292) 10.71.8 (323) 10.21.7 (295) 10.61.7 (287) 10.21.8 (167) 2.62104 10.51.8 (1679)
Black 9.81.8 (364) 9.81.8 (482) 9.81.8 (434) 9.71.8 (243) 9.62.0 (204) 9.82.1 (152) 0.88 9.81.9 (1879)
Chinese 10.92.1 (39) 11.12.1 (47) 10.91.5 (43) 10.61.9 (58) 10.82.1 (39) 10.61.7 (24) 0.80 10.81.9 (250)
Mixed 10.81.8 (104) 10.41.8 (125) 10.61.6 (108) 10.81.8 (78) 10.71.8 (56) 10.21.7 (48) 0.24 10.61.8 (519)
Others 10.41.8 (147) 10.61.7 (177) 10.62.0 (173) 10.41.7 (147) 10.11.8 (140) 10.01.6 (75) 0.05 10.41.8 (859)
Pz 1.361052 3.911058 5.581040 2.471026 7.711017 1.52106 e 1.2810150
Totalx 11.11.9 (5125) 11.01.9 (6756) 10.91.9 (7999) 10.81.9 (8953) 10.71.8 (12 545) 10.51.8 (8952) 1.0310122 10.81.9 (50 330)
Male
White 10.81.9 (3484) 10.71.9 (4393) 10.61.9 (5125) 10.51.8 (6243) 10.31.9 (9897) 10.11.9 (8328) 9.3510123 10.41.9 (37 470)
Asian 10.41.9 (388) 10.31.8 (321) 10.41.8 (276) 10.31.8 (294) 10.01.9 (254) 9.91.8 (244) 0.001 10.21.8 (1777)
Black 9.72.0 (292) 9.41.8 (319) 9.41.7 (232) 9.42.0 (193) 9.21.7 (129) 9.22.0 (122) 0.08 9.41.9 (1287)
Chinese 11.41.3 (17) 10.92.4 (25) 10.62.0 (24) 10.72.4 (27) 11.02.0 (27) 10.21.7 (20) 0.53 10.82.1 (140)
Mixed 10.62.1 (66) 10.62.0 (86) 10.11.8 (49) 10.11.9 (36) 10.41.7 (37) 9.71.5 (33) 0.11 10.31.9 (307)
Others 10.21.7 (128) 10.21.8 (110) 10.12.0 (87) 10.51.7 (92) 10.11.7 (71) 10.12.0 (62) 0.78 10.21.8 (550)
Pz 3.941025 3.511035 5.551019 1.711011 2.771010 1.74107  2.901079
Totalx 10.71.9 (4404) 10.61.9 (5296) 10.51.9 (5829) 10.41.8 (6919) 10.31.9 (10 491) 10.11.9 (8868) 3.401096 10.41.9 (41 807)
Pk 1.871023 9.291029 1.301034 2.541039 1.041061 3.011036  9.4210228
Allx 10.91.9 (9529) 10.81.9 (12 052) 10.81.9 (13 828) 10.61.9 (15 872) 10.51.9 (23 036) 10.31.8 (17 820) 6.7010234 10.61.9 (92 137)
*Participants with self-reported glaucoma in either eye were excluded. Data in format, mean  SD mmHg (n of included eyes).
yP value of 1-way analysis of variance of the means between different age groups.
zP value of 1-way analysis of variance of the means between participants with different ethnicities.
xEthnicity was unclear for 500 participants (224 female and 276 male), with mean CH of 10.31.9 mmHg (10.41.9 mmHg in female participants and 10.21.9 mmHg in male participants).
kP value of 1-way analysis of variance of the means between women and men from the same age groups.
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Table 2. Linear Regression with Corneal Hysteresis as the Dependent Variable in 93 345 Left Eyes
Corneal Hysteresis
Univariable Multivariable (n [ 91765)
Coefﬁcient (b) (95% CI) P Coefﬁcient (b) (95% CI) P
Age/10 yrs 0.26 (0.27 to 0.24) 7.1910252 0.33 (0.35 to 0.32) <10300
Gender (Ref. ¼ female ) 0.40 (0.43 to 0.38) 1.4210233 0.19 (0.23 to 0.16) 2.071027
Ethnicity (Ref. ¼ white) 5.7710221
Asian 0.28 (0.34 to 0.22) 5.371019 0.46 (0.53 to 0.40) 2.081045
Black 1.03 (1.10 to 0.96) 7.5110205 1.22 (1.29 to 1.15) 1.0310260
Chinese 0.14 (0.05 to 0.34) 0.14 0.02 (0.22 to 0.17) 0.80
Mixed 0.15 (0.27 to 0.03) 0.02 0.39 (0.51 to 0.26) 8.631010
Others 0.33 (0.43 to 0.24) 4.271012 0.60 (0.70 to 0.50) 3.521034
DBP/10 mmHg 0.12 (0.13 to 0.11) 5.671081 0.08 (0.09 to 0.06) 1.291033
SBP/10 mmHg 0.08 (0.09 to 0.07) 9.7110124  
Height/10 cm 0.19 (0.20 to 0.17) 3.1810173 0.16 (0.18 to 0.14) 4.711061
Eyesight/logMAR 0.00 (0.06 to 0.06) 0.98  
Refractive error/D 0.02 (0.01e0.02) 2.55108 0.03 (0.03e0.04) 3.061026
IOPg/mmHg 0.02 (0.02e0.03) 2.821038 0.03 (0.03e0.04) 2.321067
Smoking (Ref. ¼ Never smoker) 4.041099
Current smoker 0.46 (0.42e0.50) 3.3410100 0.42 (0.38e0.46) 1.221084
Former smoker 0.05 (0.03e0.08) 1.05104 0.10 (0.07e0.12) 7.711013
Alcohol intake frequency (Ref. ¼ never drinker) 0.26
Occasional drinker 0.04 (0.01 to 0.09) 0.15  
Monthly or more, less often than every week 0.06 (0.01e0.12) 0.03  
Weekly or more, less often than daily 0.05 (0.00e0.09) 0.048  
Daily or almost daily 0.04 (0.01 to 0.08) 0.15  
Self-reported glaucoma 0.70 (0.82 to 0.57) 1.291026 0.52 (0.64 to 0.39) 1.131015
Diabetes 0.13 (0.07e0.19) 3.50105 0.28 (0.22e0.34) 1.251020
Townsend Index 0.01 (0.01e0.01) 6.34107 0.01 (0.01e0.02) 7.82108
CI ¼ conﬁdence interval; D ¼ diopter; DBP ¼ diastolic blood pressure; IOPg ¼ Goldmanncorrelated intraocular pressure; logMAR ¼ logarithm of the
minimum angle of resolution; SBP ¼ systolic blood pressure.
Zhang et al  Associations with Corneal Hysteresis in UK Biobankhistory of eye injury in their left eye, diabetes-related eye disease,
macular degeneration, or other serious eye conditions (except for
glaucoma and cataract) in either eye. Left eyes without data on
ocular comorbidities or refractive error, with high refractive errors
(spherical equivalent >þ5 diopters [D] or <6 D), high astig-
matism (absolute value of cylindrical power >3 D), or a history of
refractive surgery were excluded. Participants with a history of
surgery or laser for glaucoma or ocular hypertension were also
excluded. Of the 93 345 left eyes remained in analysis, 1208 eyes
with self-reported glaucoma were excluded for analyses of CH
distribution.Statistical Analysis
All analyses were performed using left eye data, which were
captured after right eye data as speciﬁed in the study protocol.
This may mean left eye data are less prone to artefact, such as
blinking, in our cohort.20 We included refractive error in
analyses as the spherical equivalent in diopters (sphere
power þ 1/2 cylinder power). For glaucoma status, controls
were deﬁned as participants without self-reported glaucoma in
either eye.
A descriptive analysis of CH in left eyes stratiﬁed by age, sex,
and ethnicity was conducted after excluding all participants with
self-reported glaucoma. One-way analysis of variance was per-
formed to compare means of CH by age, sex, and ethnicity.
Associations between CH and other demographic, ocular, and
systemic factors and self-reported glaucoma were evaluated with
univariable linear regression and all factors with P < 0.05 in
univariable analysis were also analyzed with multivariable linear
regression.We analyzed the relationship between self-reported glaucoma
and CH using the following steps:1. Locally weighted scatterplot smoothing (LOWESS),21 a
method usually used to visualize the structure of data,22
was used to explore the relationship between self-
reported glaucoma and corneal hysteresis. The turning
points found on the LOWESS curve were used as nodes for
piecewise analysis.
2. Piecewise logistic regression for self-reported glaucoma
and CH was performed in 3 models after adjusting for
covariables.
3. The joint distribution of the proportion of self-reported
glaucoma, CH, and IOPg was displayed using a 3-
dimensional bar chart.We then applied linear regression to evaluate the relationships
between CH and 16 systemic diseases after adjusting for
covariables.
The 3-dimensional bar chart was plotted using Excel for Ofﬁce
365 (Microsoft Corp, Redmond, WA). All other analyses were
performed and plots generated using STATA/SE-15 (StataCorp
LLC, College Station, TX).
Results
All analyses were performed using left eye data in this study. A total
of 111 942 UKBiobank participants had available CH values for left
eyes. After data cleaning as shown in Figure 1, the mean CH was
10.601.88 mmHg (95% conﬁdence interval [CI], 10.59e10.62
mmHg) in the 92 137 eyes without self-reported glaucoma. The
distribution of mean CH stratiﬁed by age, sex, and ethnicity is1503
Figure 2. Locally weighted scatterplot smoothing (LOWESS) of self-reported glaucoma and corneal hysteresis (CH), (A) unstratiﬁed, (B) stratiﬁed by age,
and (C) stratiﬁed according to the tertiles of Goldmann-correlated intraocular pressure (IOPg).
Ophthalmology Volume 126, Number 11, November 2019summarized in Table 1. A signiﬁcant difference in CH was found
between participants with different ethnicities (P < 0.001). The
CH values were lower in black participants (9.621.87 mmHg,
95% CI, 9.56e9.69 mmHg) compared with white participants
(10.661.87 mmHg, 95% CI, 10.65e10.67 mmHg). The CH wasFigure 3. Three-dimensional bar charts showing the percentage of self-reporte
Goldmann-correlated intraocular pressure (IOPg).
1504signiﬁcantly greater in female participants (10.791.86 mmHg,
95% CI, 10.77e10.80 mmHg) compared with male participants
(10.391.88 mmHg, 95% CI, 10.37e10.40 mmHg, P < 0.001).
Overall, CH was also signiﬁcantly higher in younger people across
the whole age spectrum enrolled (mean 10.911.91mmHg, 95%d glaucoma stratiﬁed according to tertiles of corneal hysteresis (CH) and
Table 3. Logistic Regression for SelfReported Glaucoma
Model I (n [ 92 637)* Model II (n [ 92637)y Model III (n [ 91013)z
OR (95% CI) P OR (95% CI) P OR (95% CI) P
CH/mmHg
10.1 0.78 (0.73e0.82) 6.441019 0.82 (0.78e0.87) 2.201012 0.86 (0.79e0.94) 4.96104
>10.1 0.99 (0.93e1.05) 0.70 0.94 (0.88e1.00) 0.06 1.01 (0.94e1.09) 0.76
IOPg/mmHg   1.14 (1.11e1.16) 3.051040 1.13 (1.11e1.16) 1.611021
CI ¼ conﬁdence interval; IOPg ¼ Goldmanncorrelated intraocular pressure; OR ¼ odds ratio.
*Adjusting for age, sex, and ethnicity.
yAdjusting for age, sex, ethnicity, and IOPg.
zAdjusting for age, sex, ethnicity, IOPg, currently intraocular pressureelowering medication (s) using (Ref. ¼ not), diastolic blood pressure, height, visual
acuity, refractive error, smoking status, alcohol drinking frequency, diabetes status, and Townsend deprivation index.
Zhang et al  Associations with Corneal Hysteresis in UK BiobankCI, 10.87e10.95mmHg for those aged 40 to 44 years comparedwith
10.301.84 mmHg, 95%CI, 10.27e10.32 mmHg for those aged 65
to 69 years, P < 0.001).
The associations of CH were analyzed with linear regression
models as shown in Table 2. Corneal hysteresis was signiﬁcantly
associated with all included factors except for visual acuity and
alcohol intake frequency. In the multivariable linear regression
model after adjusting for covariates, CH was signiﬁcantly higher in
women (0.19 mmHg, P ¼ 2.071027), smokers (reference: never
smoked; 0.10 mmHg former smokers, P ¼ 7.711013; 0.42
mmHg current smokers, P ¼ 1.221084), participants with a
higher Townsend deprivation index (0.01 mmHg/unit,
P ¼ 7.82108), and those with self-reported diabetes (0.28
mmHg, P ¼ 1.251020). Corneal hysteresis was signiﬁcantly
lower in older participants (0.33 mmHg/10 years, P < 10300),
black participants (reference: white; 1.22 mmHg,
P ¼ 1.0310260), Asian participants (reference: white; 0.46
mmHg, P ¼ 2.081045), participants with higher blood pressure
(0.08 mmHg/10 mmHg diastolic blood pressure,P¼ 1.291033),
greater height (0.16 mmHg/10 cm, P ¼ 4.711061), greater
myopia (0.03 mmHg/D, P ¼ 3.061026), and those with self-
reported glaucoma (0.52 mmHg, P ¼ 1.131015).
Figures 2 and 3 and Table 3 show the relationship between self-
reported glaucoma and CH. Overall, lower CH was associated with
a higher proportion of self-reported glaucoma. As shown in
Figure 2A, when CH was less than approximately 10 mmHg, the
proportion of self-reported glaucoma increased markedly when
CH decreased. However, with increases in CH above 10 mmHg,
the proportion of self-reported glaucoma remained relatively stable
at approximately 1%. The LOWESS curve shapes were similar in
analyses stratiﬁed by age (Fig 2B) and IOPg (Fig 2C), with sharp
increases in the proportions of self-reported glaucoma at CH values
less than approximately 10 mmHg.
Piecewise logistic regressions were performed with a node set at
10.1 mmHg (Table 3). As shown in the Supplementary Material
(available at www.aaojournal.org), 10.1 mmHg was the smallest
node that self-reported glaucoma and CH were signiﬁcantly associ-
ated when CH was less than the node, whereas there was no associ-
ation between self-reported glaucoma and CH when CH was greater
than the node in all 3 models. When CH was less than 10.1 mmHg,
higher CH was a protective factor for self-reported glaucoma. A 1
mmHg increase in CHwas associated with an odds ratio (OR) of 0.78
(95% CI, 0.73e0.82, P < 0.001) after adjusting for age, sex, and
ethnicity inModel I, anORof 0.82 (95%CI, 0.78e0.87,P< 0.001) in
Model II (Model I with further adjusting for IOPg), and anOR of 0.86
(95%CI, 0.79e0.94,P< 0.001) inModel III (themaximally adjusted
model). When CH exceeded 10.1 mmHg, it was not associated with
self-reported glaucoma in all 3 models (Table 3).The relationship among self-reported glaucoma, CH, and IOPg
is displayed using a 3-dimensional bar chart (Fig 3). In keeping
with the analyses reported in Figure 2C and Table 3, the
proportion of self-reported glaucoma was highest in participants
with high IOPg and low CH and lowest in the participants whose
IOPg was not high and CH was not low.
We analyzed associations between CH and 16 self-reported
disorders of the thyroid gland, pituitary gland, and other immu-
nologic/systemic disorders (Table 4). Only systemic lupus
erythematosus (SLE) was signiﬁcantly associated with CH after
correction for multiple testing (P < 0.003125, Bonferroni-
corrected threshold). Corneal hysteresis was signiﬁcantly higher
in participants with self-reported SLE (0.55, 95% CI, 0.24e0.86
mmHg in the fully adjusted model).Discussion
In this large UK cohort, we have described mean CH
stratiﬁed by age, sex, and ethnicity (Table 1). We found that
CH was signiﬁcantly lower in black participants and in older
age groups, which is consistent with previously published
ﬁndings.15,23 Past studies indicate that CH and CCT are
positively associated,24-26 and CCT is negatively associated
with darker skin pigmentation.27 One explanation for the
variation in CH by ethnicity may be differences mediated
by changes in CCT. Conversely, previous publications
revealed no signiﬁcant association between CCT and
age,7,28,29 suggesting an independent association between
lower CH and older age.
Corneal hysteresis was signiﬁcantly higher in smokers in
our cohort (both current and former smokers). A previous,
smaller study had suggested this, but results were incon-
clusive.30 The mechanisms underlying the relationship
between smoking and corneal changes are unknown,31,32
and the association between smoking and corneal ectatic
disorders is controversial.33,34 An epidemiologic study
showed a marked reduction in the incidence of keratoconus
among smokers,34 implying altered corneal biomechanics.
This is supported by experimental evidence of collagen
crosslinking by formaldehyde, a constituent of cigarette
smoke, with resulting increased resistance to
collagenases.34 Smoking has also been reported to damage
the tear ﬁlm35,36 and possibly the corneal endothelium,37
which may inﬂuence CCT and CH measurements. We1505
Table 4. Linear Regressions for Corneal Hysteresis and SelfReported Disorders of the Thyroid Gland, Pituitary Gland, or Other Immunologic/Systemic Disorders*
Corneal Hysteresis
Model 1y Model 2y Model 3y
PrevalencezCoefﬁcient (b) P Coefﬁcient (b) P Coefﬁcient (b) P
Thyroid disorders
Hyperthyroidism/thyrotoxicosis/Grave’s disease 0.02 (0.16 to 0.12) 0.74 0.02 (0.16 to 0.12) 0.75 0.04 (0.18 to 0.10) 0.61 1.05% (0.94%)
Hypothyroidism/myxedema 0.02 (0.04 to 0.07) 0.57 0.02 (0.03 to 0.08) 0.43 0.02 (0.03 to 0.08) 0.42 6.46% (6.50%)
Thyroid goiter 0.22 (0.43 to 0.01) 0.04x 0.22 (0.43 to 0.02) 0.04x 0.19 (0.39 to 0.02) 0.07 0.13% (0.40%)
Thyroiditis 0.20 (0.26 to 0.66) 0.40 0.20 (0.26 to 0.66) 0.39 0.21 (0.24 to 0.67) 0.36 0.07% (0.09%)
Disorders of pituitary gland
Acromegaly 1.09 (0.12e2.06) 0.03x 1.11 (0.15e2.07) 0.02x 1.22 (0.21e2.22) 0.02x 0.02% (0.02%)
Hypopituitarism 0.25 (0.82 to 0.32) 0.40 0.26 (0.83 to 0.31) 0.38 0.24 (0.80 to 0.33) 0.42 0.05% (0.06%)
Hyperprolactinemia 0.06 (0.87 to 0.75) 0.89 0.03 (0.87 to 0.81) 0.95 0.03 (0.84 to 0.78) 0.95 0.02% (0.02%)
Pituitary adenoma/tumor 0.09 (0.51 to 0.34) 0.69 0.07 (0.49 to 0.35) 0.74 0.02 (0.44 to 0.39) 0.92 0.09% (0.10%)
Immunological/systemic disorders
SLE 0.64 (0.31e0.96) 0.0001k 0.64 (0.32e0.97) 0.0001k 0.55 (0.24 to 0.86) 0.0006k 0.17% (0.16%)
Sjögren’s syndrome/sicca syndrome 0.10 (0.29 to 0.48) 0.63 0.11 (0.28 to 0.50) 0.58 0.13 (0.26 to 0.52) 0.51 0.13% (0.11%)
Rheumatoid arthritis 0.11 (0.01 to 0.24) 0.07 0.12 (0.00e0.24) 0.06 0.08 (0.04 to 0.20) 0.20 1.51% (1.25%)
Vasculitis 0.04 (0.19 to 0.27) 0.72 0.05 (0.18 to 0.27) 0.68 0.07 (0.16 to 0.30) 0.56 0.37% (0.39%)
Dermatopolymyositis 0.24 (1.02 to 0.54) 0.54 0.25 (1.02 to 0.52) 0.52 0.26 (1.05 to 0.52) 0.51 0.03% (0.02%)
Scleroderma/systemic sclerosis 0.04 (0.62 to 0.71) 0.90 0.03 (0.63 to 0.70) 0.92 0.07 (0.55 to 0.70) 0.82 0.04% (0.03%)
Psoriasis 0.10 (0.03 to 0.22) 0.12 0.10 (0.03 to 0.22) 0.13 0.07 (0.06 to 0.19) 0.28 1.49% (1.32%)
Sarcoidosis 0.29 (0.56 to 0.01) 0.04x 0.27 (0.55 to 0.01) 0.06 0.18 (0.46 to 0.11) 0.22 0.27% (0.26%)
SLE ¼ systemic lupus erythematosus.
*Participants with selfreported glaucoma in either eye were excluded.
yModel I, adjusted for age, sex and ethnicity; Model II, adjusted for age, sex, ethnicity and Goldmann-correlated intraocular pressure (IOPg); Model III, adjusted for age, sex, ethnicity, IOPg, height, diastolic
blood pressure, visual acuity, smoking status, refractive error, diabetes status, and Townsend deprivation index.
zPrevalence % ¼ Proportion using all UK Biobank participants with available data (n ¼ 375 064). (%) ¼ Proportion within the sample with available data after data cleaning (n ¼ 69 973).
xP < 0.05.
kP < 0.003125 (Bonferroni-corrected threshold for multiple testing).
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Zhang et al  Associations with Corneal Hysteresis in UK Biobankfound no signiﬁcant association between alcohol
consumption and CH.
Our ﬁndings in Figures 2 and 3, and Table 3 suggest that
CH may be useful in glaucoma risk stratiﬁcation in clinical
practice. Figure 2 and Table 3 indicate that a CH value of
10.1 mmHg could play a role as cutoff point in clinical
practice to evaluate a patient’s risk of glaucoma. When
CH is less than 10.1mmHg, lower CH may be associated
with a higher risk of glaucoma (OR, 1.16; 95% CI,
1.07e1.26 per mmHg CH decrease in the fully adjusted
model). When CH was greater than 10.1 mmHg, the rate
of self-reported glaucoma remained relatively stable with
further increases in CH. Medeiros et al38 reported that lower
CH with values below 10 mmHg was a risk factor for
glaucoma progression.
Measurement of CH demonstrates good repeatability,39
and there are no signiﬁcant diurnal ﬂuctuations,26,40
making CH measurement a potentially attractive addition
to current glaucoma risk stratiﬁcation methods. Corneal
hysteresis has been shown to be lower in different types of
glaucoma, including open-angle glaucoma, angle-closure
glaucoma, normal-tension glaucoma, pseudoexfoliative
glaucoma, and congenital glaucoma.41-46 Lower CH is also
positively associated with visual ﬁeld progression.8,38
Some studies have found a positive association between
CH and glaucoma-related changes in optic disc
morphology,47-49 whereas others found no such relation-
ship.50-52 Unlike CH, IOP and CCT measurements are
limited by signiﬁcant diurnal variation.26,40,53-55
Figures 2C and 3 and Table 3 show that CH and IOPg
could be analyzed together in clinical settings to evaluate
glaucoma risk, because the risk of self-reported glau-
coma was highest in participants with low CH and high
IOPg and lowest in participants whose IOPg was not high
and CH was not low.
In analyses for associations between CH and self-
reported disorders shown in Table 4, only SLE was
signiﬁcantly associated with CH at P < 0.003
(Bonferroni-corrected threshold for multiple testing). We
found that CH was signiﬁcantly higher in participants
with SLE, which is contradictory to the result in a case-
control study that reported CH was lower in patients
with SLE.56 Lower CH has also been reported in thyroid
eye disease;10 however, we did not ﬁnd an association
between CH and thyroid disorders. We also did not ﬁnd
associations between CH and rheumatoid arthritis or
psoriasis as previously published.11,12 Participants with
acromegaly in our cohort had higher CH values (at P <
0.05), in agreement with ﬁndings by Ozkok et al;13
however, our results were not signiﬁcant after correction
for multiple testing. Former studies have yielded variable
results when evaluating CH in diabetes.57-60 Our study
shows higher CH among patients with diabetes as previ-
ously reported,60,61 which is supported by the former
ﬁndings that having diabetes decreased the odds of having
more severe keratoconus.62 The increased cross-linking of
corneal collagen63 in diabetes may contribute to the higher
CH. However, 2 small sample studies64,65 reported no
signiﬁcant change of CH after cross-linking operation in
keratoconus. Another possible mechanism is themorphologic66 and functional alteration67 of corneal
endothelium in diabetic patients, leading to abnormal
hydration and increased thickness of cornea,66,67 which
is associated with higher CH.
Study Strengths and Limitations
The large sample size and standardized techniques are major
strengths of our study, allowing us to detect and quantify
small effects. However, the study is limited by the fact that
all disease statuses were self-reported by participants, which
can result in misclassiﬁcation error.68 The UK Biobank has
a low response rate of 5.5%, which limits external validity.
With respect to glaucoma, there will be an under-
ascertainment of disease because approximately 50% of
cases may not have been diagnosed.68 Meanwhile,
participants with ocular hypertension, suspected glaucoma,
or cataracts may report a diagnosis of glaucoma. The
potential impact of these errors is unknown. We excluded
participants with a history of surgery or laser for
glaucoma or ocular hypertension. A potential confounding
variable in the reported association between CH and
glaucoma is the use of IOP-lowering medications, which
may signiﬁcantly alter corneal biomechanical proper-
ties.9,69,70 The binary variable of current, regular IOP-
lowering medication use versus no use in this study may
oversimplify the effects of different medications on corneal
biomechanics. Corneal hysteresis and IOPg in this study
were measured together using the same instrument and
adjusting one for the other makes interpretation difﬁcult.
Despite this, we found a weak correlation between them
(Pearson correlation coefﬁcient, rho ¼ 0.045) in the sample
after data cleaning. Investigation into the association be-
tween CH and diseases including glaucoma, SLE, and dia-
betes is scarce, and we anticipate that future research will
build on our ﬁndings.
In conclusion, our study offers CH reference values for
future research and clinical practice. We also report asso-
ciations between CH and age, sex, ethnicity, smoking status,
refractive error, self-reported glaucoma, diabetes, and SLE,
which may be important when interpreting CH. Corneal
hysteresis measurement may play a role in clinical practice
for glaucoma and other ocular and systemic conditions.
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